Partial response of pulmonary adenocarcinoma with symptomatic brain metastasis to nivolumab plus high-dose oral corticosteroid: a case report

Partial response of pulmonary adenocarcinoma with symptomatic brain metastasis to nivolumab plus high-dose oral corticosteroid: a case report

Abstract Background Nivolumab, a monoclonal antibody targeting the programmed death-1 receptor, is indicated in locally advanced or metastatic non-small cell lung cancer, with progression after platinum-based chemotherapy. Up-to-now, few data are available concerning brain activity of this treatment...

Full description

Bibliographic Details
Main Authors: Hélène Pluchart, Julian Pinsolle, Julien Cohen, Gilbert R. Ferretti, Pierrick Bedouch, Matteo Giaj Levra, Anne-Claire Toffart, Denis Moro-Sibilot
Format: Article
Language:English
Published: BMC 2017-07-01
Series:Journal of Medical Case Reports
Subjects:
Case report
Pulmonary adenocarcinoma
Brain metastasis-related symptoms
Immunotherapy
Immunomodulating drugs
Nivolumab
Online Access:http://link.springer.com/article/10.1186/s13256-017-1334-z

Internet

http://link.springer.com/article/10.1186/s13256-017-1334-z

Similar Items